Cargando…
Phase-3 Randomized Controlled Trials on Exclusion of Participants With Kidney Disease in COVID-19
Autores principales: | Chewcharat, Api, Chang, Yuan-Ting, Sise, Meghan E., Bhattacharyya, Roby P., Murray, Megan B., Nigwekar, Sagar U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577277/ https://www.ncbi.nlm.nih.gov/pubmed/33106779 http://dx.doi.org/10.1016/j.ekir.2020.10.010 |
Ejemplares similares
-
The association between olfactory and gustatory dysfunction and chronic kidney disease
por: Chewcharat, Api, et al.
Publicado: (2022) -
The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis
por: Chewcharat, Api, et al.
Publicado: (2022) -
COVID-19 Survival and its impact on chronic kidney disease
por: LONG, JOSHUA D., et al.
Publicado: (2022) -
The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials
por: Chewcharat, Api, et al.
Publicado: (2020) -
Prescription Patterns of Osteoporosis Medications in Patients With Advanced CKD: A Retrospective Cohort Study
por: Portales-Castillo, Ignacio A., et al.
Publicado: (2021)